4-azidophenylpropionamide has been researched along with Fatty Liver in 1 studies
*Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, N; Murakoshi, M; Takekoshi, S | 1 |
1 other study(ies) available for 4-azidophenylpropionamide and Fatty Liver
| Article | Year |
|---|---|
Immunohistochemical and biochemical studies in 4-aminopyrazolopyrimidine (4-APP)-induced fatty liver.
Topics: Animals; Azides; Fatty Liver; Free Radicals; Glutathione Peroxidase; Immunohistochemistry; Lipid Metabolism; Lipid Peroxidation; Liver; Male; Rats; Rats, Inbred Strains | 2002 |